Position in INSM
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,499,588
-$551,292 QoQ
Shares Held
32,823
+32.5% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#236
of 663 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MML INVESTORS SERVICES, LLC holds $86,570,832 across 61 Biotechnology names. INSM ranks #5 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,907 | $19,326,274 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,117 | $11,296,674 | |
| 3 | ARGX |
Argenx SE
|
6,825 | $6,332,030 | |
| 4 | EXEL |
Exelixis, Inc.
|
73,531 | $4,000,821 | |
| 5 | INSM |
INSMED Inc
This page
|
32,823 | $3,499,588 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,949 | $2,994,947 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
11,712 | $2,822,240 | |
| 8 | RPRX |
Royalty Pharma plc
|
49,942 | $2,800,247 |
All Filings in INSM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,499,588 | 32,823 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $4,050,880 | 24,773 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $5,950,427 | 34,190 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,904,410 | 41,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,933,171 | 49,018 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,380,934 | 31,209 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,584,813 | 22,955 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,620,673 | 22,201 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $1,092,368 | 16,304 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||